# TYRA BIOSCIENCES INC (TYRA)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/TYRA/

- Reporting holders: 3
- Reported value: $29.4K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Versant Capital Management, Inc](https://holderbook.com/funds/1735057-versant-capital-management-inc/) | $17.9K | 819 | 0.0% | 6 |
| [GAMMA Investing LLC](https://holderbook.com/funds/2010235-gamma-investing-llc/) | $9.9K | 452 | 0.0% | 6 |
| [Farther Finance Advisors, LLC](https://holderbook.com/funds/1992825-farther-finance-advisors-llc/) | $1.6K | 75 | 0.0% | 5 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 3 | $29.4K |
| Q2 2026 | 173 | $2.3B |
| Q1 2026 | 164 | $2.6B |
| Q4 2025 | 135 | $1.5B |
| Q3 2025 | 117 | $780.6M |
| Q2 2025 | 121 | $542.4M |
| Q1 2025 | 116 | $500.1M |
| Q4 2024 | 112 | $675.9M |
| Q3 2024 | 96 | $1.1B |
| Q2 2024 | 76 | $683.9M |
| Q1 2024 | 76 | $775.8M |
| Q4 2023 | 65 | $442.0M |